APA (7th ed.) Citation

Shinozaki, S., Miura, K., Tahara, T., & Yamamoto, H. Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose. MDPI AG.

Chicago Style (17th ed.) Citation

Shinozaki, Satoshi, Kouichi Miura, Toshiyuki Tahara, and Hironori Yamamoto. Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose. MDPI AG.

MLA (9th ed.) Citation

Shinozaki, Satoshi, et al. Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose. MDPI AG.